Vasopressin: Why not in severe traumatic disease? Jesús Abelardo Barea-Mendoza; Juan Antonio Llompart-Pou; Adrian Marcos-Morales; Mario Chico-Fernández;

Ten take-home messages on vasopressin use in critically ill patients Ricard Ferrer; Pedro Castro; Carol Lorencio; Josman Monclou; Pilar Marcos; Ana Ochagavia; Juan Carlos Ruíz-Rodríguez; Josep Trenado; Christian Villavicencio; Juan Carlos Yébenes; Lluís Zapata;

Key laboratory changes in severe trauma, a different pattern for each clinical phenotype Adrián Marcos-Morales; Jesús Abelardo Barea Mendoza; Marcos Valiente Fernández; Carlos García Fuentes; Fernando Calvo Boyero; Cecilia Cueto-Felgueroso; Judith Gutiérrez Gutiérrez; Francisco de Paula Delgado Moya; Carolina Mudarra Reche; Susana Bermejo Aznárez; Alfonso Lagares; Mario Chico Fernández;